Sun Pharma Halts Eye Drug Production at Assam Facility
Indian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at its Assam facility due to failures in the company's quality management system. A joint inspection found lapses affecting drug safety and quality, leading to a recall of several eye-drop brands. Significant adverse cases raised concerns about product contamination, prompting further investigation.
Economic Times··Assam



